IL-5 R alpha

IL-5 R alpha

IL-5 R alpha 詳細

Molecule Name
Interleukin-5 receptor subunit alpha
分子の別称
IL5Ra,CD125
Drug Development Progress
治験薬の数2
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
Interleukin 5 Receptor, Alpha,Interleukin-5 Receptor Subunit Alpha,HSIL5R3,Interleukin-5 Receptor Alpha Chain,CDw125,Interleukin-5 Receptor alpha Subunit,Interleukin 5 Receptor Type 3,CD125 Antigen,Interleukin 5 Receptor Subunit Alpha,IL-5 Receptor Subunit Alpha,IL-5R-Alpha,IL5R,IL5RA,CD125,IL-5RA,IL-5R Subunit Alpha
バックグランド
Interleukin-5 receptor subunit alpha (IL5RA) is also known as IL-5 receptor subunit alpha, IL-5R subunit alpha and CD125,which is a single-pass type I membrane protein that belongs to the type I cytokine receptor family and type 5 subfamily.IL5R, a heterodimer of an alpha and a beta subunit, is expressed on eosinophils and basophils. IL5RA / CD125 is the receptor for interleukin-5 (IL5) and the alpha chain can bind to IL5. The WSXWS motif of IL5RA appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.The beta subunit of IL5R is common to the IL3, IL5 and GM-CSF receptors.

IL-5 R alpha 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
IL-5 CAR-T Cell Therapy (Zhejiang University)Phase 1 ClinicalZhejiang University
Hematologic Diseases; Neoplasms
詳細
TrabikibartCSL-311Phase 1 ClinicalCsl Ltd
Asthma
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
BenralizumabKHK-4563; MEDI-563; BIW-8405; BIW-8405-IL-5RApprovedBiowa Inc, Medimmune LlcFasenra, 凡舒卓United StatesAsthmaAstrazeneca Ab2017-11-14
Asthma; Asthma, Exercise-Induced; Bronchiectasis; Chronic Urticaria; Dermatitis; Dermatitis, Atopic; Drug Hypersensitivity Syndrome; Eczema; Eosinophilia; Eosinophilic Asthma; Eosinophilic Esophagitis; Eosinophilic gastroenteritis (EG); Eosinophilic Granulomatosis With Polyangiitis; Gastroenteritis; Genetic Diseases, Inborn; Granulomatosis with Polyangiitis; Hematologic Diseases; Hypereosinophilic Syndrome; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases; Leukocyte Disorders; Nasal Polyps; Pemphigoid, Bullous; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Sinusitis; Skin Diseases; Skin Diseases, Eczematous; Skin Diseases, Genetic
詳細